J
John P. Walsh
Researcher at Sir Charles Gairdner Hospital
Publications - 224
Citations - 12365
John P. Walsh is an academic researcher from Sir Charles Gairdner Hospital. The author has contributed to research in topics: Thyroid function & Medicine. The author has an hindex of 54, co-authored 199 publications receiving 10565 citations. Previous affiliations of John P. Walsh include Hudson Institute of Medical Research & Diabetes Australia.
Papers
More filters
Journal ArticleDOI
British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008
Brian Gazzard,Jane Anderson,Abdel Babiker,Marta Boffito,Gary Brook,Gary Brough,Duncan Churchill,Ben Cromarty,Satyajit Das,Martin Fisher,Andrew L. Freedman,Anna Maria Geretti,Margaret A. Johnson,Saye Khoo,Clifford Leen,Devaki Nair,Barry Peters,Andrew N. Phillips,Deenan Pillay,Anton Pozniak,John P. Walsh,Ed Wilkins,Ian S. Williams,Matthew Williams,M Youle +24 more
TL;DR: The 2008 BHIVA Guidelines have been updated to incorporate all the new relevant information since the last iteration and all the peer-reviewed publications and important, potentially treatment-changing abstracts from the last 2 years have been reviewed.
Journal ArticleDOI
Subclinical hypothyroidism and the risk of coronary heart disease and mortality.
Nicolas Rodondi,Wendy P. J. den Elzen,Douglas C. Bauer,Anne R. Cappola,Salman Razvi,John P. Walsh,Bjørn Olav Åsvold,Giorgio Iervasi,Misa Imaizumi,Tinh-Hai Collet,Alexandra Bremner,Patrick Maisonneuve,José Augusto Sgarbi,Kay-Tee Khaw,Mark Vanderpump,Anne B. Newman,Jacques Cornuz,Jayne A. Franklyn,Rudi G. J. Westendorp,Eric Vittinghoff,Jacobijn Gussekloo +20 more
TL;DR: Subclinical hypothyroidism is associated with an increased risk of CHD events and CHD mortality in those with higher TSH levels, particularly inThose with a TSH concentration of 10 mIU/L or greater.
Journal ArticleDOI
Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.
John P. Walsh,Alexandra Bremner,Max Bulsara,Peter O'Leary,Peter J. Leedman,Peter Feddema,Valdo Michelangeli +6 more
TL;DR: Subclinical hypothyroidism may be an independent risk factor for coronary heart disease and is examined in subjects with and without subclinical thyroid dysfunction to end of 2001.
Journal ArticleDOI
Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality
Tinh-Hai Collet,Jacobijn Gussekloo,Douglas C. Bauer,Wendy P. J. den Elzen,Anne R. Cappola,Philippe Balmer,Giorgio Iervasi,Bjørn Olav Åsvold,José Augusto Sgarbi,Henry Völzke,Baris Gencer,Rui M. B. Maciel,Sabrina Molinaro,Alexandra Bremner,Robert Luben,Patrick Maisonneuve,Jacques Cornuz,Anne B. Newman,Kay-Tee Khaw,Rudi G. J. Westendorp,Jayne A. Franklyn,Eric Vittinghoff,John P. Walsh,Nicolas Rodondi +23 more
TL;DR: Endogenous subclinical hyperthyroidism is associated with increased risks of total,CHD mortality, and incident AF, with highest risks of CHD mortality and AF when thyrotropin level is lower than 0.10 mIU/L.
Journal ArticleDOI
Dysferlin is a Plasma Membrane Protein and is Expressed Early in Human Development
Louise V.B. Anderson,Keith Davison,Jennifer A. Moss,Carol Young,Michael Cullen,John P. Walsh,Margaret A. Johnson,Rumaisa Bashir,S. Britton,Sharon Keers,Zohar Argov,Ibrahim Mahjneh,Françoise Fougerousse,Jacques S. Beckmann,Kate Bushby +14 more
TL;DR: Analysis of human fetal tissue showed that dysferlin was expressed at the earliest stages of development examined, at Carnegie stage 15 or 16 (embryonic age 5-6 weeks).